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Case ReportsLong-term biventricular support with rotary blood pumps in a
patient with a noncontractile heart
Taichi Sakaguchi, MD, Shunsuke Saito, MD, Daisuke Yoshioka, MD, and Yoshiki Sawa, MD, Osaka, JapanFIGURE 1. Intraoperative view showing implanted Jarvik 2000 right ven-
tricular assist device and DuraHeart left ventricular assist device. Reprinted
3Despite advances in continuous-flow ventricular assist
devices (VADs), their long-term use for biventricular
support is still limited. We report a case of successful long-
term biventricular support using 2 rotary pumps implanted
in a patient completely lacking native cardiac contractility.
CASE REPORT
A 34-year-old woman (body surface area, 1.56 m2)
underwent emergency biventricular VAD implantation
with paracorporeal pulsatile devices (Nipro Medical Corp,
Miami, Fla) for fulminant myocarditis. After 6 months,
biventricular VAD conversion to implantable continuous-
flow pumpswas performed for long-term support. The intra-
operative findings showed that both ventricles were not
dilated and were totally noncontractile, serving only as inert
blood conduits. A DuraHeart (Terumo Heart Inc, Ann Ar-
bor, Mich) was chosen as the left VAD because the inflow
cannulas of both devices are virtually the same size and
the previous Nipro inflow cuff was usable. A Jarvik 2000
(Jarvik Heart Inc, New York, NY) was placed on the right
ventricle. The anterior leaflet of the tricuspid valve was
sutured to the anterior wall of the right ventricle to prevent
inflow obstruction and to create a single atrioventricular
pouch for systemic venous return. Because the patient had
severe pulmonary insufficiency, the pulmonary valve was
closed with a running suture. Each outflow graft was
anastomosed to the previous outflow graft, and no banding
was added to the right VAD outflow graft (Figure 1).
Her postoperative course was uneventful, and she
successfully underwent heart transplantation after 884
days of biventricular support.with permission.DISCUSSION
Several reports have been published of implantable
continuous-flow pumps being used for long-term biventric-
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The Journal of Thoracic and CaHeart Institute Group, in which 17 patients were implanted
with 2 HeartWare HVAD pumps (Heartware International
Inc, Framingham, Mass). In those patients, the 30-day
survival was 82%, with the longest survival period reaching
440 days. The preoperative left and right ventricular
ejection fraction value was 20.2%  12.4% and 29.9%
 11.7%, respectively.1
The present patient had lost all ventricular contractility
owing to massive myocardial necrosis (Figure 2) and had
been in nonpulsatile circulation for >2 years. Patients
supported with continuous-flow VADs commonly still
have some degree of pulsatile blood pressure caused by
native ventricular contraction. In this context, little is known
regarding the long-term influence of nonpulsatile circulation
on the human body. In our patient, no significant changes
were observed in the laboratory values showing end-organrdiovascular Surgery c Volume 146, Number 4 e29
FIGURE 2. Histologic findings of the explanted heart showing an
extremely thin left ventricular wall with marked fibrosis (elastica van
Gieson’s stain).
Case Reportsfunction. Furthermore, an exercise stress test showed
increased left VAD flow even at a fixed pump speed. Frazier
et al2 used a calf model in which both native ventricles were
excised and replaced with 2 continuous-flow VADs. An ex-
ercise test demonstrated increased flow in both VADs.2 Our
results have confirmed their experimental findings, suggest-
ing that even without native ventricular contraction, biven-
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e30 The Journal of Thoracic and Cardiovascular Surgdemand. We consider that these hemodynamic properties
imply the possibility of clinical use of continuous-flow arti-
ficial hearts currently being tested in animal models.
When implanting 2 rotary pumps for biventricular support,
concern exists about a flow imbalance between the pulmo-
nary and systemic circulation. After the implant operation,
the systemic and pulmonary vascular resistances become dy-
namic and are further influenced by use of inotropes, discon-
tinuation of mechanical ventilation, and other factors. These
altered hemodynamic states could exacerbate the flow imbal-
ance during the perioperative period, especially in patients
with a noncontractile heart. In the present case, the first extu-
bation failed owing to severe pulmonary congestion caused
by right VAD overflow.3 Interestingly, after resolution of
these perioperative hemodynamic fluxes, the management
became easier, with no additional pulmonary congestion
noted. A natural flow balance appears to be achieved by the
autoregulatory properties of continuous-flow VADs.4
The currently available pulsatile total artificial hearts
have numerous restrictions. We believe that the present
successful case will promote the clinical use of rotary blood
pumps in patients with biventricular failure for bridging
and, even, destination therapy.
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assist deviceKarine Nubret, MD,a Philippe Mauriat, MD,a Franc¸ois Roubertie, MD,b Chloe James, MD,c,d,e
Nadir Tafer, MD,a and Alexandre Ouattara, MD, PhD,a,d,e Bordeaux and Pessac, FranceThe ventricular assist device (VAD), as a bridge to heart
transplantation, is being increasingly used in patients of
all ages who are experiencing refractory heart failure. In
these patients, massive bleeding remains a leading and
challenging complication. Among the possible causes, the
occurrence of acquired von Willebrand disease (avWD)
has been reported in adult patients.1 Indeed, the loss of
high-molecular-weight (HMW) von Willebrand factor
(vWF) multimers because of shear stress, similar to that
seen in aortic stenoses,1 is frequently observed in patients
with axial flow in a left VAD.2,3ery c October 2013
